Advanced Orthopedic Technologies, Implants, and Regenerative Products Global Market Report 2024

The advanced orthopedic technologies, implants, and regenerative products market size has grown strongly in recent years. It will grow from $63.99 billion in 2023 to $68.21 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%. The expansion observed in the historical period can be attributed to factors such as the aging population, an increase in the incidence of orthopedic conditions, the prevalence of joint replacement surgeries, reimbursement policies, and the globalization of orthopedic markets.

The advanced orthopedic technologies, implants, and regenerative products market size is expected to see strong growth in the next few years. It will grow to $85.26 billion in 2028 at a compound annual growth rate (CAGR) of 5.7%. The anticipated growth in the forecast period can be attributed to advancements in nano-scale orthopedic treatments, the adoption of patient-specific instrumentation, the integration of precision medicine in orthopedics, the shift towards value-based healthcare, and the growth of ambulatory surgery centers (ASCs). Major trends in the forecast period include advances in regenerative medicine, the implementation of robotics-assisted surgery, the use of 3D printing technology, advancements in biomaterials, the development of smart implants, the use of biodegradable implants, the integration of augmented reality (AR) and virtual reality (VR), collaborations with data analytics companies, and a focus on sustainable orthopedics.

The anticipated rise in the occurrence of orthopedic disorders is set to drive the growth of the market for advanced orthopedic technologies, implants, and regenerative products. Orthopedic disorders, affecting the musculoskeletal system, prompt an increased demand for advanced solutions, encompassing technologies, implants, and regenerative products for diagnosing, treating, and managing symptoms and causes of orthopedic diseases. For example, data from June 2023 indicates that in the UK alone, around 450,000 people suffer from rheumatoid arthritis, 190,000 adults have psoriatic arthritis, and 10 million individuals contend with osteoarthritis. This reflects a notable increase from 2021 figures of 430,000 people with rheumatoid arthritis, 100,000 adults with psoriatic arthritis, and 8.5 million people with osteoarthritis. Consequently, the escalating prevalence of orthopedic disorders underpins the growth of the market for advanced orthopedic technologies, implants, and regenerative products.

The increasing frequency of sports injuries is poised to fuel the expansion of the advanced orthopedic technologies, implants, and regenerative products market in the foreseeable future. As participation in sports and physical activities rises, the incidence of sports-related injuries grows, necessitating orthopedic technologies and regenerative products for effective recovery. Notably, statistics from 2022 highlight a 20% increase in sports and recreation injuries in 2021, followed by an additional 12% rise in 2022, according to the National Safety Council. This surge in sports injuries contributes to the growing demand for advanced orthopedic solutions, further propelling the market.

Technological advancements represent a prominent trend in the advanced orthopedic technologies, implants, and regenerative products market. Leading companies in the industry are embracing new technologies to maintain their market positions. For instance, Orthofix Medical Inc., a US-based medical device company, introduced the Mariner deformity pedicle screw system in January 2023. This system is designed to provide a comprehensive solution with clinical goals in mind, combining biologics and 7-D Flash navigation for precise and modular platform expansion. The Mariner deformity system streamlines the surgical process for deformity surgery while minimizing the number of surgical trays required.

Innovation to cater to consumer needs is a focal point for major companies in the advanced orthopedic technologies, implants, and regenerative products market. Notably, the development of a robotic-arm-assisted surgical system enhances surgical precision and capabilities. Stryker Corporation, a US-based medical technology company, launched the Mako Total Knee 2.0 in March 2023. This robotic-arm-assisted system enhances the total knee arthroplasty (TKA) procedure, offering an intuitive design, adaptable workflow, and innovative features such as a digital tensioner for assessing knee stability without additional instrumentation.

In August 2022, CONMED Corporation, a US-based medical technology company, acquired Biorez Inc., marking a significant step in advancing orthopedic technologies, implants, and regenerative solutions. Biorez Inc., a medical device start-up, focuses on bio-inductive collagen scaffold technology for soft tissue recovery in sports medicine, aligning seamlessly with CONMED's existing product offerings.

Major companies operating in the advanced orthopedic technologies, implants, and regenerative products market report are Johnson & Johnson, Medtronic PLC, Stryker Corporation, B Braun Medical Inc., Zimmer Biomet Holdings Inc., Smith & Nephew PLC, Arthrex Inc., Integra LifeSciences Holdings Corporation, Lepu Medical Technology Co Ltd., NuVasive Inc., CONMED Corporation, Globus Medical Inc., Wright Medical Group N.V., Bioventus LLC, Orthofix Medical Inc., Alphatec Holdings Inc., Acumed LLC, MiMedx Group Inc., Exactech Inc., Anika Therapeutics Inc., DJO Global Inc., Misonix Inc., Osiris Therapeutics Inc., Bacterin International Holdings Inc., Cerapedics Inc., Histogenics Corporation, Kuros Biosciences AG, Life Spine Inc., Aurora Spine Corporation, Camber Spine Technologies LLC.

North America was the largest region in the advanced orthopedic technologies, implants, and regenerative products market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced orthopedic technologies, implants, and regenerative products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the advanced orthopedic technologies, implants, and regenerative products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The main categories of advanced orthopedic technologies, implants, and regenerative products include implants and regenerative products. Implants refer to tools or materials used to fix or replace a body component, often made of inert substances. Other products in this category include orthopedic fixation devices, orthopedic replacement devices, orthopedic prosthetics, orthopedic braces and support products, spinal implants and surgical devices, arthroscopy instruments, Ortho biologics, bone graft substitutes, and various devices for specific anatomical sites such as the hip and pelvis, foot and ankle, knee and thigh, hand and wrist, shoulder, arm and elbow, spine, and craniomaxillofacial. These products find applications in hospitals, ambulatory surgical centers, and specialty clinics.

The advanced orthopedic technologies, implants, and regenerative products research report is one of a series of new reports that provides advanced orthopedic technologies, implants, and regenerative products market statistics, including advanced orthopedic technologies, implants, and regenerative products industry global market size, regional shares, competitors with an advanced orthopedic technologies, implants, and regenerative products market share, detailed advanced orthopedic technologies, implants, and regenerative products market segments, market trends and opportunities, and any further data you may need to thrive in the advanced orthopedic technologies, implants, and regenerative products industry. This advanced orthopedic technologies, implants, and regenerative products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The advanced orthopedic technologies, implants, and regenerative products market consists of revenues earned by entities by providing pain management, physical therapy, and spine care. The market value includes the value of related goods sold by the service provider or included within the service offering. The advanced orthopedic technologies, implants, and regenerative products market also includes of sales of internal fixation devices, external fixation devices, ankle replacement devices, and solid ankle cushion heel prostheses. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).


The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.